Cancer BiologybioRxivPreprint
FOLFIRINOX Combined with GPX4 Inhibition Induces Ferroptosis and Defines Redox-Based Therapeutic Subgroups in Pancreatic Cancer
Carlos Lacalle-González, Carlos Lopez-Blazquez, Miguel Ángel Hidalgo-León…·Javier Martínez‐Useros
This paper evaluates combining FOLFIRINOX with GPX4 inhibition to induce ferroptosis in pancreatic cancer, identifying redox-based biomarkers for treatment stratification.
1 citation